Compare JRSH & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JRSH | DRIO |
|---|---|---|
| Founded | 2016 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.8M | 70.6M |
| IPO Year | 2017 | 2013 |
| Metric | JRSH | DRIO |
|---|---|---|
| Price | $5.68 | $6.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $4.00 | ★ $35.00 |
| AVG Volume (30 Days) | ★ 74.7K | 15.2K |
| Earning Date | 02-09-2026 | 05-14-2026 |
| Dividend Yield | ★ 5.68% | N/A |
| EPS Growth | 485.71 | ★ 1559.02 |
| EPS | 0.13 | ★ 1.75 |
| Revenue | ★ $166,263,870.00 | $7,394,000.00 |
| Revenue This Year | $11.64 | $20.27 |
| Revenue Next Year | $10.06 | $47.58 |
| P/E Ratio | $43.85 | ★ $3.87 |
| Revenue Growth | 14.03 | ★ 43.02 |
| 52 Week Low | $2.85 | $5.84 |
| 52 Week High | $5.81 | $17.74 |
| Indicator | JRSH | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 59.73 | 45.02 |
| Support Level | $4.37 | $6.13 |
| Resistance Level | $5.81 | $8.10 |
| Average True Range (ATR) | 0.21 | 0.27 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 86.21 | 29.86 |
Jerash Holdings (US) Inc along with its subsidiaries, is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers, including Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen, which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, and Speedo. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.